Praxis Precision Medicines, Inc. PRAX Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s operating income?
- Praxis Precision Medicines, Inc. (PRAX) reported operating income of -$105.86M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s operating income changed year-over-year?
- Praxis Precision Medicines, Inc.'s operating income decreased by 41.7% year-over-year, from -$74.73M to -$105.86M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s operating income?
- Over 4 years (2021 to 2025), Praxis Precision Medicines, Inc.'s operating income has grown at a 18.2% compound annual growth rate (CAGR), from -$167.33M to -$326.2M.
- What does operating income mean?
- The profit a company makes from its core business before interest and taxes.
- How do you interpret operating income?
- Positive values indicate a self-sustaining business model, while negative values indicate an operating loss.
- How does operating income compare across companies?
- A critical metric for comparing operational efficiency across companies regardless of capital structure.